2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB sub(1) receptor
Two types of endogenous cannabinoid-receptor agonists have been identified thus far. They are the ethanolamides of polyunsaturated fatty acids--arachidonoyl ethanolamide (anandamide) is the best known compound in the amide series--and 2-arachidonoyl glycerol, the only known endocannabinoid in the es...
Gespeichert in:
Veröffentlicht in: | Proceedings of the National Academy of Sciences - PNAS 2001-03, Vol.98 (7), p.3662-3665 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3665 |
---|---|
container_issue | 7 |
container_start_page | 3662 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 98 |
creator | Hanus, L Abu-Lafi, S Fride, E Breuer, A Vogel, Z Shalev, DE Kustanovich, I Mechoulam, R |
description | Two types of endogenous cannabinoid-receptor agonists have been identified thus far. They are the ethanolamides of polyunsaturated fatty acids--arachidonoyl ethanolamide (anandamide) is the best known compound in the amide series--and 2-arachidonoyl glycerol, the only known endocannabinoid in the ester series. We report now an example of a third, ether-type endocannabinoid, 2- arachidonyl glyceryl ether (noladin ether), isolated from porcine brain. The structure of noladin ether was determined by mass spectrometry and nuclear magnetic resonance spectroscopy and was confirmed by comparison with a synthetic sample. It binds to the CB sub(1) cannabinoid receptor (K sub(i) = 21.2 plus or minus 0.5 nM) and causes sedation, hypothermia, intestinal immobility, and mild antinociception in mice. It binds weakly to the CB sub(2) receptor (K sub(i) > 3 mu M). |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_17829148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17829148</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_178291483</originalsourceid><addsrcrecordid>eNqNjL0OgjAURjtoIv68w52MJpIUxACjEo0P4OJESrlATb3Ftgy8vQw-gNN3knPyzVjAeZyGWRInC7Z07sU5z08ZD9gzDs9WyE7VhkYNrR4l2gnQd2gPIAiQatMimcGBaA0p58E0MGmQgkhUioyqobiAG6pdtAeLEntv7JrNG6Edbn67Ytvb9VHcw96az4DOl2_lJGotCKfzMkqzOI-S7Ph3-AWvHEQB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17829148</pqid></control><display><type>article</type><title>2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB sub(1) receptor</title><source>JSTOR Archive Collection A-Z Listing</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Hanus, L ; Abu-Lafi, S ; Fride, E ; Breuer, A ; Vogel, Z ; Shalev, DE ; Kustanovich, I ; Mechoulam, R</creator><creatorcontrib>Hanus, L ; Abu-Lafi, S ; Fride, E ; Breuer, A ; Vogel, Z ; Shalev, DE ; Kustanovich, I ; Mechoulam, R</creatorcontrib><description>Two types of endogenous cannabinoid-receptor agonists have been identified thus far. They are the ethanolamides of polyunsaturated fatty acids--arachidonoyl ethanolamide (anandamide) is the best known compound in the amide series--and 2-arachidonoyl glycerol, the only known endocannabinoid in the ester series. We report now an example of a third, ether-type endocannabinoid, 2- arachidonyl glyceryl ether (noladin ether), isolated from porcine brain. The structure of noladin ether was determined by mass spectrometry and nuclear magnetic resonance spectroscopy and was confirmed by comparison with a synthetic sample. It binds to the CB sub(1) cannabinoid receptor (K sub(i) = 21.2 plus or minus 0.5 nM) and causes sedation, hypothermia, intestinal immobility, and mild antinociception in mice. It binds weakly to the CB sub(2) receptor (K sub(i) > 3 mu M).</description><identifier>ISSN: 0027-8424</identifier><language>eng</language><subject>2-Arachidonyl glyceryl ether</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2001-03, Vol.98 (7), p.3662-3665</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Hanus, L</creatorcontrib><creatorcontrib>Abu-Lafi, S</creatorcontrib><creatorcontrib>Fride, E</creatorcontrib><creatorcontrib>Breuer, A</creatorcontrib><creatorcontrib>Vogel, Z</creatorcontrib><creatorcontrib>Shalev, DE</creatorcontrib><creatorcontrib>Kustanovich, I</creatorcontrib><creatorcontrib>Mechoulam, R</creatorcontrib><title>2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB sub(1) receptor</title><title>Proceedings of the National Academy of Sciences - PNAS</title><description>Two types of endogenous cannabinoid-receptor agonists have been identified thus far. They are the ethanolamides of polyunsaturated fatty acids--arachidonoyl ethanolamide (anandamide) is the best known compound in the amide series--and 2-arachidonoyl glycerol, the only known endocannabinoid in the ester series. We report now an example of a third, ether-type endocannabinoid, 2- arachidonyl glyceryl ether (noladin ether), isolated from porcine brain. The structure of noladin ether was determined by mass spectrometry and nuclear magnetic resonance spectroscopy and was confirmed by comparison with a synthetic sample. It binds to the CB sub(1) cannabinoid receptor (K sub(i) = 21.2 plus or minus 0.5 nM) and causes sedation, hypothermia, intestinal immobility, and mild antinociception in mice. It binds weakly to the CB sub(2) receptor (K sub(i) > 3 mu M).</description><subject>2-Arachidonyl glyceryl ether</subject><issn>0027-8424</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqNjL0OgjAURjtoIv68w52MJpIUxACjEo0P4OJESrlATb3Ftgy8vQw-gNN3knPyzVjAeZyGWRInC7Z07sU5z08ZD9gzDs9WyE7VhkYNrR4l2gnQd2gPIAiQatMimcGBaA0p58E0MGmQgkhUioyqobiAG6pdtAeLEntv7JrNG6Edbn67Ytvb9VHcw96az4DOl2_lJGotCKfzMkqzOI-S7Ph3-AWvHEQB</recordid><startdate>20010327</startdate><enddate>20010327</enddate><creator>Hanus, L</creator><creator>Abu-Lafi, S</creator><creator>Fride, E</creator><creator>Breuer, A</creator><creator>Vogel, Z</creator><creator>Shalev, DE</creator><creator>Kustanovich, I</creator><creator>Mechoulam, R</creator><scope>7TK</scope></search><sort><creationdate>20010327</creationdate><title>2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB sub(1) receptor</title><author>Hanus, L ; Abu-Lafi, S ; Fride, E ; Breuer, A ; Vogel, Z ; Shalev, DE ; Kustanovich, I ; Mechoulam, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_178291483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>2-Arachidonyl glyceryl ether</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hanus, L</creatorcontrib><creatorcontrib>Abu-Lafi, S</creatorcontrib><creatorcontrib>Fride, E</creatorcontrib><creatorcontrib>Breuer, A</creatorcontrib><creatorcontrib>Vogel, Z</creatorcontrib><creatorcontrib>Shalev, DE</creatorcontrib><creatorcontrib>Kustanovich, I</creatorcontrib><creatorcontrib>Mechoulam, R</creatorcontrib><collection>Neurosciences Abstracts</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hanus, L</au><au>Abu-Lafi, S</au><au>Fride, E</au><au>Breuer, A</au><au>Vogel, Z</au><au>Shalev, DE</au><au>Kustanovich, I</au><au>Mechoulam, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB sub(1) receptor</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><date>2001-03-27</date><risdate>2001</risdate><volume>98</volume><issue>7</issue><spage>3662</spage><epage>3665</epage><pages>3662-3665</pages><issn>0027-8424</issn><abstract>Two types of endogenous cannabinoid-receptor agonists have been identified thus far. They are the ethanolamides of polyunsaturated fatty acids--arachidonoyl ethanolamide (anandamide) is the best known compound in the amide series--and 2-arachidonoyl glycerol, the only known endocannabinoid in the ester series. We report now an example of a third, ether-type endocannabinoid, 2- arachidonyl glyceryl ether (noladin ether), isolated from porcine brain. The structure of noladin ether was determined by mass spectrometry and nuclear magnetic resonance spectroscopy and was confirmed by comparison with a synthetic sample. It binds to the CB sub(1) cannabinoid receptor (K sub(i) = 21.2 plus or minus 0.5 nM) and causes sedation, hypothermia, intestinal immobility, and mild antinociception in mice. It binds weakly to the CB sub(2) receptor (K sub(i) > 3 mu M).</abstract></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 2001-03, Vol.98 (7), p.3662-3665 |
issn | 0027-8424 |
language | eng |
recordid | cdi_proquest_miscellaneous_17829148 |
source | JSTOR Archive Collection A-Z Listing; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | 2-Arachidonyl glyceryl ether |
title | 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB sub(1) receptor |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A11%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2-Arachidonyl%20glyceryl%20ether,%20an%20endogenous%20agonist%20of%20the%20cannabinoid%20CB%20sub(1)%20receptor&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Hanus,%20L&rft.date=2001-03-27&rft.volume=98&rft.issue=7&rft.spage=3662&rft.epage=3665&rft.pages=3662-3665&rft.issn=0027-8424&rft_id=info:doi/&rft_dat=%3Cproquest%3E17829148%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17829148&rft_id=info:pmid/&rfr_iscdi=true |